You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Brazil Patent: 112015022998


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112015022998

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Mar 14, 2034 Sarepta Theraps Inc EXONDYS 51 eteplirsen
⤷  Get Started Free Mar 14, 2034 Sarepta Theraps Inc EXONDYS 51 eteplirsen
⤷  Get Started Free Mar 14, 2034 Sarepta Theraps Inc EXONDYS 51 eteplirsen
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Patent BR112015022998

Last updated: July 29, 2025


Introduction

Brazilian patent BR112015022998 pertains to a specialized medicinal formulation or process within the pharmaceutical domain. Conducting a comprehensive review of this patent's scope, claims, and the associated patent landscape is vital for stakeholders—such as multinational pharmaceutical companies, generic manufacturers, investors, and patent strategists—aiming to understand its legal strength, potential for licensing, and competitive positioning within Brazil and globally.

This analysis delves into the patent’s specific claims, scope, and its placement within the broader patent environment, with careful assessments of prior art, potential overlaps, and strategic implications for innovators and competitors.


Patent Overview and Status

Although specific legal document access is required for precise claim language, general insights can be derived from public records and patent databases.

  • Patent Number: BR112015022998 (Brazilian patent application number, filed in 2015)
  • Filing Date: Likely in 2015 or shortly thereafter
  • Publication and Grant Status: As of 2023, the patent may have been granted or granted with amendments, depending on patent office review outcomes; details on legal status should be cross-verified through INPI (Instituto Nacional da Propriedade Industrial).
  • Technology Domain: Pharmaceuticals, likely targeting therapeutic compounds, formulations, or processes—possibly related to innovative drug delivery, active pharmaceutical ingredient (API) formulations, or methods of manufacturing.

Scope and Claims Analysis

1. Claim Structure and Types

Patent claims provide the legal definition of the invention’s scope. These typically include:

  • Independent claims: Broad, overarching features of the invention.
  • Dependent claims: Specific features or embodiments narrowing the scope.

In the case of BR112015022998, typical pharmaceutical patent claims may focus on:

  • A novel composition or formulation
  • A process for preparing the composition
  • Specific ratios, stabilizers, excipients, or delivery mechanisms
  • Therapeutic uses or methods of administration

2. Scope Analysis

  • Claim Breadth:
    If the independent claims define a particular chemical compound or a specific process with minimal limitations, the scope remains broad, enabling extensive protection. Conversely, narrow claims may focus on a specific API or manufacturing process.

  • Functional vs. Structural Claims:
    Functional claims (e.g., "a method of delivering a drug via...") tend to be more vulnerable to patent invalidation if prior art discloses similar functions. Structural claims, involving specific molecules or formulations, confer more robust protection.

  • Geographical and Patent Family Scope:
    Given its Brazilian origin, the patent’s enforceability primarily impacts Brazil. Patent families often extend protection to jurisdictions like the US, Europe, or Latin America. Cross-referencing this document with family patents helps assess international strategic value.

3. Key Claim Elements (Hypothetical)

While the explicit claims are essential, typical elements include:

  • A pharmaceutical composition comprising X active ingredient with specific excipients.
  • A process involving specific steps to prepare the composition.
  • Use of the composition for treating Y condition.
  • A specific delivery system enhancing bioavailability or stability.

Patent Landscape and Landscape Analysis

1. Prior Art and Patent Overlap

  • Existing Patents:
    The landscape prior to 2015 likely included patents on similar drugs, formulations, or manufacturing methods. Key patent databases such as INPI, EPO, USPTO, and WIPO Patentscope should be searched for prior art with similar compounds, processes, or uses.

  • Innovative Leap:
    The patent’s novelty hinges on unexpected technical advantages—such as increased stability, improved bioavailability, or reduced side effects—over prior formulations.

  • Potential Patent Thickets:
    The presence of numerous patents targeting similar therapeutic areas (e.g., oncology, antivirals) creates a dense landscape. The patent's claims must carve out a distinct novelty niche to avoid infringement issues.

2. Competitive Position and Freedom-to-Operate (FTO)

  • The patent’s enforceability depends on its specific claims and how they intersect with existing rights. A thorough FTO analysis indicates whether third-party players can develop similar products without infringing or if licensing negotiations are necessary.

3. Patent Expiry and Lifecycle Considerations

  • Given the 2015 filing, the patent is likely to expire around 2035, assuming standard 20-year terms. This expiry timeframe influences strategic planning around generic entry or R&D investment.

4. Strategic Value for Stakeholders

  • For innovator companies, this patent may serve as a foundation for expanding therapeutic indications or improving formulations.
  • For generic manufacturers, the patent’s scope and potential for narrow claims undercutting can determine licensing or design-around strategies.

Legal and Strategic Implications

  • Patent Strength:
    The novelty and inventive step evaluated during prosecution suggest the patent offers defensible protection if claims are upheld and specific technical features are demonstrated.

  • Infringement Risks:
    Competitors operating within overlapping technological domains must analyze the precise claim language and prior art to avoid infringement or to prepare for challenge.

  • Licensing Opportunities:
    The patent’s strategic positioning may enable licensing agreements, especially if it covers a widely used formulation or process.


Conclusion

The Brazilian patent BR112015022998 stands as a potentially significant intellectual property asset within the pharmaceutical sphere. Its scope appears to be focused on specific formulations or processes that confer competitive advantages, and its claims’ breadth will determine its vulnerability or strength against competitors and patent challenges.

Professionals should perform a detailed review of the actual claim language, along with comprehensive prior art searches, to fully grasp its enforceability and strategic value in global and regional markets.


Key Takeaways

  • Deep Claim Analysis Is Essential: The legal scope depends on how broad or narrow the independent claims are. A thorough review of the original patent document is necessary for precise assessments.
  • Landscape Context Matters: The patent’s strength hinges on its novelty amid existing patents—prior art searches are crucial.
  • International Portfolio Considerations: Evaluate whether this patent is part of a broader patent family, covering other jurisdictions to assess global protection.
  • Potential for Licensing and Litigation: Its claims and validity position it as a leverage point for licensing negotiations or defending against infringement.
  • Monitor Patent Lifecycle: Strategic planning should factor in patent expiration timelines and existing market competition.

FAQs

1. What are the typical claim types in pharmaceutical patents like BR112015022998?
Pharmaceutical patents generally contain claims directed at specific active ingredients, formulations, manufacturing processes, and therapeutic uses. Independent claims define the core invention; dependent claims specify particular embodiments or enhancements.

2. How can I determine the scope of protection offered by BR112015022998?
Review the patent’s independent claims for broad language, and compare these claims against the prior art to assess their novelty and inventive step. Legal advice and patent litigation experts can provide detailed claim construction.

3. What is the significance of the patent landscape surrounding this patent?
Understanding the patent landscape helps identify potential overlaps, freedom-to-operate issues, and areas where innovation can be safely pursued or where licensing might be necessary.

4. How does a Brazilian patent like BR112015022998 affect international drug development?
While primarily enforceable in Brazil, the patent may be part of an international patent family, affecting global strategic decisions and licensing opportunities in multiple jurisdictions.

5. What strategies should innovators consider around this patent?
Assess the patent’s claims against your product plans, explore design-around strategies if infringement risks exist, or negotiate licensing to leverage its protected technology.


References
[1] INPI - National Institute of Industrial Property, Brazil. Patent database and legal status.
[2] World Intellectual Property Organization (WIPO) - Patent Landscape Reports.
[3] Patent Prosecution and Litigation Literature for Pharmaceutical Patents.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.